Prophylactically Decontaminating Human Islet Product for Safe Clinical Application: Effective and Potent Method

作者: Meirigeng Qi , Keiko Omori , Yoko Mullen , Brian McFadden , Luis Valiente

DOI: 10.1097/TXD.0000000000000574

关键词: IsletPancreatic islet transplantationSurgeryBioinformaticsPancreasMedicineCefazolinOrgan transplantationIsolation (health care)TransplantationGood manufacturing practice

摘要: Pancreatic islet transplantation is a promising approach in treating insulin-dependent diabetes.1-3 Currently, over 900 patients globally have been transplanted with allografts.4 Islet requires isolating islets from mass pancreatic acinar tissue, which involves extensive tissue manipulation and rigorous regulatory approvals to ensure safe high-quality final product for type 1 diabetes (T1D).5-7 Studies whole organ showed that graft failure was attributed systemic infection due the contamination preservation solution.8-10 The issue further exacerbated isolation, multiple steps, including of pancreas portion duodenum and/or spleen attached, trimming decontamination pancreas, perfusion enzyme, digestion, collection, washing purification, culturing, collection islets.11 Although, process manufacturing carried out current good practice (cGMP) facility, risk introducing at any stage procedure still remains.12-14 Aside media used decontamination, all other solutions throughout isolation are prepared within cGMP facility without addition antimicrobial agents prevent potential allergic reaction recipient. T1D more vulnerable infection, especially after required immunosuppressive regimen allograft rejection.15 Thus, it extremely important take measures during transplantation. With advancement as standardized treatment strategy clinical setting, eventually may require biologic license application so effective would be into patients.6,16 Therefore, sterility testing becomes one critical checkpoints. Hence, understand route rate this implement an prevention plan safety potency preparations. A limited number large-scale studies published regarding issues process,15,17-19 little described effect antiseptic on outcome process. In fact, most recent article related topic 10 years ago,18 evaluated use Cefazolin Amphotericin B However, protocol Clinical Transplantation Consortium centers only uses single antibiotic (Cefazolin) dip decontaminate organ.20 We hypothesize using decrease or eliminate product. Herein, we report comprehensive review analysis rates frequency by specific microbial species.

参考文章(29)
Jayaram Lakshmaiah Narayana, Jyh-Yih Chen, Antimicrobial peptides: Possible anti-infective agents. Peptides. ,vol. 72, pp. 88- 94 ,(2015) , 10.1016/J.PEPTIDES.2015.05.012
Meirigeng Qi, Luis Valiente, Brian McFadden, Keiko Omori, Shiela Bilbao, Jemily Juan, Jeffrey Rawson, Stephen Scott, Kevin Ferreri, Yoko Mullen, Mohamed El-Shahawy, Donald Dafoe, Fouad Kandeel, Ismail H. Al-Abdullah, The Choice of Enzyme for Human Pancreas Digestion is a Critical Factor for Increasing the Success of Islet Isolation. Transplantation direct. ,vol. 1, pp. 1- 9 ,(2015) , 10.1097/TXD.0000000000000522
Rodolfo Alejandro, Franca B. Barton, Bernhard J. Hering, Steve Wease, 2008 Update from the Collaborative Islet Transplant Registry. Transplantation. ,vol. 86, pp. 1783- 1788 ,(2008) , 10.1097/TP.0B013E3181913F6A
R. PATRICK WOOD, TERRY MELENDEZ, ALAN N. LANGNAS, DIANNE KELLY, The viability of microorganisms in preservation solutions. Transplantation. ,vol. 51, pp. 239- 242 ,(1991) , 10.1097/00007890-199101000-00039
Darin J. Weber, FDA regulation of allogeneic islets as a biological product Cell Biochemistry and Biophysics. ,vol. 40, pp. 19- 22 ,(2004) , 10.1385/CBB:40:3:19
Meirigeng Qi, Katie Kinzer, Kirstie K. Danielson, Joan Martellotto, Barbara Barbaro, Yong Wang, James T. Bui, Ron C. Gaba, Grace Knuttinen, Raquel Garcia-Roca, Ivo Tzvetanov, Andrew Heitman, Maureen Davis, James J. McGarrigle, Enrico Benedetti, Jose Oberholzer, Five-year follow-up of patients with type 1 diabetes transplanted with allogeneic islets: the UIC experience Acta Diabetologica. ,vol. 51, pp. 833- 843 ,(2014) , 10.1007/S00592-014-0627-6
BURT R. MEYERS, MERYL H. MENDELSON, STEVEN LANSMAN, Microbial contamination of solid-organ donor transport fluids leading to systemic infection. Transplantation. ,vol. 53, pp. 1383- ,(1992) , 10.1097/00007890-199206000-00048
A.M. James Shapiro, Camillo Ricordi, Bernhard J. Hering, Hugh Auchincloss, Robert Lindblad, R. Paul Robertson, Antonio Secchi, Mathias D. Brendel, Thierry Berney, Daniel C. Brennan, Enrico Cagliero, Rodolfo Alejandro, Edmond A. Ryan, Barbara DiMercurio, Philippe Morel, Kenneth S. Polonsky, Jo-Anna Reems, Reinhard G. Bretzel, Federico Bertuzzi, Tatiana Froud, Raja Kandaswamy, David E.R. Sutherland, George Eisenbarth, Miriam Segal, Jutta Preiksaitis, Gregory S. Korbutt, Franca B. Barton, Lisa Viviano, Vicki Seyfert-Margolis, Jeffrey Bluestone, Jonathan R.T. Lakey, International Trial of the Edmonton Protocol for Islet Transplantation The New England Journal of Medicine. ,vol. 355, pp. 1318- 1330 ,(2006) , 10.1056/NEJMOA061267
Kenneth L Brayman, Edic Stephanian, Arthur J Matas, Walter Schmidt, William D Payne, David ER Sutherland, Paul F Gores, John S Najarian, David L Dunn, Analysis of Infectious Complications Occurring After Solid-Organ Transplantation Archives of Surgery. ,vol. 127, pp. 38- 48 ,(1992) , 10.1001/ARCHSURG.1992.01420010044007
E. Linetsky, C. Ricordi, Regulatory Challenges in Manufacturing of Pancreatic Islets Joint Conference of the Cell Transplant Society (CTS), International Pancreas and Islet Transplant Association (IPITA), and International Xenotransplantation Association (IXA), Sections of the Transplantation Society (TTS). ,vol. 40, pp. 424- 426 ,(2008) , 10.1016/J.TRANSPROCEED.2008.01.027